AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 157 filers reported holding AKERO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,808,441 | +8.3% | 273,002 | 0.0% | 0.31% | +13.7% |
Q2 2023 | $12,746,463 | +12.7% | 273,002 | -7.6% | 0.27% | +35.5% |
Q1 2023 | $11,305,907 | -34.6% | 295,502 | -6.3% | 0.20% | -45.2% |
Q4 2022 | $17,289,510 | -25.3% | 315,502 | -53.6% | 0.36% | -40.1% |
Q3 2022 | $23,154,000 | +80.3% | 680,000 | -50.0% | 0.61% | +121.5% |
Q2 2022 | $12,843,000 | -33.4% | 1,359,052 | -0.0% | 0.28% | -31.8% |
Q1 2022 | $19,286,000 | -32.9% | 1,359,152 | 0.0% | 0.40% | -9.2% |
Q4 2021 | $28,746,000 | -16.5% | 1,359,152 | -11.8% | 0.44% | -1.3% |
Q3 2021 | $34,429,000 | -16.2% | 1,540,465 | -7.0% | 0.45% | +6.4% |
Q2 2021 | $41,102,000 | -14.5% | 1,656,673 | 0.0% | 0.42% | -10.9% |
Q1 2021 | $48,060,000 | +12.4% | 1,656,673 | 0.0% | 0.48% | +39.7% |
Q4 2020 | $42,742,000 | -16.2% | 1,656,673 | 0.0% | 0.34% | -11.9% |
Q3 2020 | $51,009,000 | +93.7% | 1,656,673 | +56.8% | 0.39% | +60.2% |
Q2 2020 | $26,332,000 | +39.4% | 1,056,673 | +18.6% | 0.24% | -5.5% |
Q1 2020 | $18,893,000 | -4.5% | 891,201 | 0.0% | 0.26% | +3.7% |
Q4 2019 | $19,780,000 | +16.0% | 891,201 | +18.9% | 0.25% | +5.1% |
Q3 2019 | $17,049,000 | +109.5% | 749,424 | +76.3% | 0.23% | +28.6% |
Q2 2019 | $8,139,000 | – | 425,000 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
University of Wisconsin Foundation | 103,816 | $5,251,013 | 6.02% |
Boxer Capital, LLC | 1,676,733 | $84,809,155 | 4.52% |
Redmile Group, LLC | 1,769,684 | $89,510,617 | 4.26% |
Ghost Tree Capital, LLC | 250,000 | $12,645,000 | 4.16% |
Logos Global Management LP | 600,000 | $30,348,000 | 4.05% |
COMMODORE CAPITAL LP | 565,000 | $28,577,700 | 3.34% |
Yiheng Capital Management, L.P. | 1,221,674 | $61,792,271 | 3.15% |
SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $10,116,000 | 3.07% |
Atlas Venture Life Science Advisors, LLC | 359,251 | $18,170,915 | 2.81% |
Perceptive Advisors | 1,619,425 | $81,910,517 | 2.73% |